FORTRESS BIOTECH, INC. received a stock award from AVENUE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2025ACC: 0001415889-25-009621
10% Owner
Since Dec 2022
+33.72K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
33.72K acquired
Non-Derivative Transactions1
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+33.72K
Price / share
—
Trade value
—
% of position
11.4%
3/31/2025
294.80K→328.52K
Total
Net shares
+33.72K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 3/31/2025 | A · Award | +33.72K | — | — | 11.4% | 294.80K | 328.52K |
| Total | +33.72K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported